These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 10419498)

  • 1. Bethlem myopathy and engineered collagen VI triple helical deletions prevent intracellular multimer assembly and protein secretion.
    Lamandé SR; Shields KA; Kornberg AJ; Shield LK; Bateman JF
    J Biol Chem; 1999 Jul; 274(31):21817-22. PubMed ID: 10419498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinked collagen VI tetramers and reduced microfibril formation as a result of Bethlem myopathy and introduced triple helical glycine mutations.
    Lamandé SR; Mörgelin M; Selan C; Jöbsis GJ; Baas F; Bateman JF
    J Biol Chem; 2002 Jan; 277(3):1949-56. PubMed ID: 11707460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A heterozygous splice site mutation in COL6A1 leading to an in-frame deletion of the alpha1(VI) collagen chain in an italian family affected by bethlem myopathy.
    Pepe G; Giusti B; Bertini E; Brunelli T; Saitta B; Comeglio P; Bolognese A; Merlini L; Federici G; Abbate R; Chu ML
    Biochem Biophys Res Commun; 1999 May; 258(3):802-7. PubMed ID: 10329467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New molecular mechanism for Ullrich congenital muscular dystrophy: a heterozygous in-frame deletion in the COL6A1 gene causes a severe phenotype.
    Pan TC; Zhang RZ; Sudano DG; Marie SK; Bönnemann CG; Chu ML
    Am J Hum Genet; 2003 Aug; 73(2):355-69. PubMed ID: 12840783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the alpha3(VI) chain in collagen VI assembly. Expression of an alpha3(VI) chain lacking N-terminal modules N10-N7 restores collagen VI assembly, secretion, and matrix deposition in an alpha3(VI)-deficient cell line.
    Lamandé SR; Sigalas E; Pan TC; Chu ML; Dziadek M; Timpl R; Bateman JF
    J Biol Chem; 1998 Mar; 273(13):7423-30. PubMed ID: 9516440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant mitochondria in a Bethlem myopathy patient with a homozygous amino acid substitution that destabilizes the collagen VI α2(VI) chain.
    Zamurs LK; Idoate MA; Hanssen E; Gomez-Ibañez A; Pastor P; Lamandé SR
    J Biol Chem; 2015 Feb; 290(7):4272-81. PubMed ID: 25533456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy.
    Baker NL; Mörgelin M; Peat R; Goemans N; North KN; Bateman JF; Lamandé SR
    Hum Mol Genet; 2005 Jan; 14(2):279-93. PubMed ID: 15563506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collagen VI microfibril formation is abolished by an {alpha}2(VI) von Willebrand factor type A domain mutation in a patient with Ullrich congenital muscular dystrophy.
    Tooley LD; Zamurs LK; Beecher N; Baker NL; Peat RA; Adams NE; Bateman JF; North KN; Baldock C; Lamandé SR
    J Biol Chem; 2010 Oct; 285(43):33567-33576. PubMed ID: 20729548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COL6A1 genomic deletions in Bethlem myopathy and Ullrich muscular dystrophy.
    Pepe G; Lucarini L; Zhang RZ; Pan TC; Giusti B; Quijano-Roy S; Gartioux C; Bushby KM; Guicheney P; Chu ML
    Ann Neurol; 2006 Jan; 59(1):190-5. PubMed ID: 16278855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular consequences of dominant Bethlem myopathy collagen VI mutations.
    Baker NL; Mörgelin M; Pace RA; Peat RA; Adams NE; Gardner RJ; Rowland LP; Miller G; De Jonghe P; Ceulemans B; Hannibal MC; Edwards M; Thompson EM; Jacobson R; Quinlivan RC; Aftimos S; Kornberg AJ; North KN; Bateman JF; Lamandé SR
    Ann Neurol; 2007 Oct; 62(4):390-405. PubMed ID: 17886299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mouse model for dominant collagen VI disorders: heterozygous deletion of Col6a3 Exon 16.
    Pan TC; Zhang RZ; Arita M; Bogdanovich S; Adams SM; Gara SK; Wagener R; Khurana TS; Birk DE; Chu ML
    J Biol Chem; 2014 Apr; 289(15):10293-10307. PubMed ID: 24563484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autosomal recessive Bethlem myopathy: A clinical, genetic and functional study.
    Caria F; Cescon M; Gualandi F; Pichiecchio A; Rossi R; Rimessi P; Cotti Piccinelli S; Gallo Cassarino S; Gregorio I; Galvagni A; Ferlini A; Padovani A; Bonaldo P; Filosto M
    Neuromuscul Disord; 2019 Sep; 29(9):657-663. PubMed ID: 31471117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The C5 domain of the collagen VI alpha3(VI) chain is critical for extracellular microfibril formation and is present in the extracellular matrix of cultured cells.
    Lamandé SR; Mörgelin M; Adams NE; Selan C; Allen JM
    J Biol Chem; 2006 Jun; 281(24):16607-14. PubMed ID: 16613849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exon skipping mutations in collagen VI are common and are predictive for severity and inheritance.
    Lampe AK; Zou Y; Sudano D; O'Brien KK; Hicks D; Laval SH; Charlton R; Jimenez-Mallebrera C; Zhang RZ; Finkel RS; Tennekoon G; Schreiber G; van der Knaap MS; Marks H; Straub V; Flanigan KM; Chu ML; Muntoni F; Bushby KM; Bönnemann CG
    Hum Mutat; 2008 Jun; 29(6):809-22. PubMed ID: 18366090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recessive COL6A2 C-globular missense mutations in Ullrich congenital muscular dystrophy: role of the C2a splice variant.
    Zhang RZ; Zou Y; Pan TC; Markova D; Fertala A; Hu Y; Squarzoni S; Reed UC; Marie SKN; Bönnemann CG; Chu ML
    J Biol Chem; 2010 Mar; 285(13):10005-10015. PubMed ID: 20106987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The N-terminal N5 subdomain of the alpha 3(VI) chain is important for collagen VI microfibril formation.
    Fitzgerald J; Mörgelin M; Selan C; Wiberg C; Keene DR; Lamandé SR; Bateman JF
    J Biol Chem; 2001 Jan; 276(1):187-93. PubMed ID: 11027693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Missense mutation in a von Willebrand factor type A domain of the alpha 3(VI) collagen gene (COL6A3) in a family with Bethlem myopathy.
    Pan TC; Zhang RZ; Pericak-Vance MA; Tandan R; Fries T; Stajich JM; Viles K; Vance JM; Chu ML; Speer MC
    Hum Mol Genet; 1998 May; 7(5):807-12. PubMed ID: 9536084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced collagen VI causes Bethlem myopathy: a heterozygous COL6A1 nonsense mutation results in mRNA decay and functional haploinsufficiency.
    Lamandé SR; Bateman JF; Hutchison W; McKinlay Gardner RJ; Bower SP; Byrne E; Dahl HH
    Hum Mol Genet; 1998 Jun; 7(6):981-9. PubMed ID: 9580662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete sequence of the 23-kilobase human COL9A3 gene. Detection of Gly-X-Y triplet deletions that represent neutral variants.
    Paassilta P; Pihlajamaa T; Annunen S; Brewton RG; Wood BM; Johnson CC; Liu J; Gong Y; Warman ML; Prockop DJ; Mayne R; Ala-Kokko L
    J Biol Chem; 1999 Aug; 274(32):22469-75. PubMed ID: 10428822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of common and private mutations in the COL6A1 gene of patients with Bethlem myopathy.
    Lucioli S; Giusti B; Mercuri E; Vanegas OC; Lucarini L; Pietroni V; Urtizberea A; Ben Yaou R; de Visser M; van der Kooi AJ; Bönnemann C; Iannaccone ST; Merlini L; Bushby K; Muntoni F; Bertini E; Chu ML; Pepe G
    Neurology; 2005 Jun; 64(11):1931-7. PubMed ID: 15955946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.